Sitting on gains in Eli Lilly, Nvidia? Ask these questions before your next move

After standout 2023 performances, Eli Lilly and Nvidia are red hot to start 2024, leaving shareholders with a high-class problem: What to do with a winner?

Source: CNBC

Earnings

Jim Cramer warns against novice day trading, calls zero-day options 'pure greed'

21. December 2024

Earnings

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

20. December 2024

Earnings

The Mega Millions jackpot is nearing $1 billion — but that’s not the only reason lottery sales could see a holiday spike

20. December 2024

Earnings

Winnebago posts its first adjusted loss in years, as consumers want cheaper RVs

20. December 2024

Sitting on gains in Eli Lilly, Nvidia? Ask these questions before your next move

Related Articles

Jim Cramer warns against novice day trading, calls zero-day options 'pure greed'

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

The Mega Millions jackpot is nearing $1 billion — but that’s not the only reason lottery sales could see a holiday spike

Winnebago posts its first adjusted loss in years, as consumers want cheaper RVs